APDN logo

Applied DNA Sciences (APDN) Cash From Operations

Annual CFO

-$13.71 M
-$7.49 M-120.52%

September 30, 2024


Summary


Performance

APDN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPDNcash flowmetrics:

Quarterly CFO

-$3.25 M
+$245.60 K+7.03%

September 1, 2024


Summary


Performance

APDN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPDNcash flowmetrics:

TTM CFO

-$13.71 M
-$569.30 K-4.33%

September 1, 2024


Summary


Performance

APDN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAPDNcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

APDN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-120.5%-1.2%-24.5%
3 y3 years-2.4%-1615.4%-90.9%
5 y5 years-99.8%-1615.4%-90.9%

APDN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-120.5%at low-1615.4%+13.5%-120.5%at low
5 y5-year-120.5%at low-1615.4%+31.1%-120.5%at low
alltimeall time<-9999.0%at low-1615.4%+31.1%<-9999.0%at low

Applied DNA Sciences Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-$13.71 M(+120.5%)
-
-
Sep 2024
-
-$3.25 M(-7.0%)
-$13.71 M(+4.3%)
Jun 2024
-
-$3.49 M(+8.9%)
-$13.14 M(+19.3%)
Mar 2024
-
-$3.21 M(-14.6%)
-$11.02 M(+45.1%)
Dec 2023
-
-$3.76 M(+40.2%)
-$7.59 M(+22.1%)
Sep 2023
-$6.22 M(-30.7%)
-$2.68 M(+95.7%)
-$6.22 M(-8.5%)
Jun 2023
-
-$1.37 M(-738.6%)
-$6.80 M(-5.4%)
Mar 2023
-
$214.40 K(-109.0%)
-$7.18 M(-6.2%)
Dec 2022
-
-$2.38 M(-26.9%)
-$7.66 M(-14.7%)
Sep 2022
-$8.98 M(-32.9%)
-$3.26 M(+85.7%)
-$8.98 M(-13.9%)
Jun 2022
-
-$1.75 M(+569.8%)
-$10.43 M(+5.1%)
Mar 2022
-
-$261.90 K(-92.9%)
-$9.93 M(-23.3%)
Dec 2021
-
-$3.70 M(-21.4%)
-$12.93 M(-3.4%)
Sep 2021
-$13.39 M(+20.1%)
-$4.71 M(+277.0%)
-$13.39 M(+14.8%)
Jun 2021
-
-$1.25 M(-61.8%)
-$11.66 M(-13.1%)
Mar 2021
-
-$3.27 M(-21.3%)
-$13.42 M(+6.8%)
Dec 2020
-
-$4.16 M(+39.3%)
-$12.57 M(+12.8%)
Sep 2020
-$11.14 M(+62.4%)
-$2.98 M(-0.8%)
-$11.14 M(+12.1%)
Jun 2020
-
-$3.01 M(+24.3%)
-$9.94 M(+21.0%)
Mar 2020
-
-$2.42 M(-11.4%)
-$8.21 M(+1.6%)
Dec 2019
-
-$2.73 M(+53.7%)
-$8.08 M(+17.7%)
Sep 2019
-$6.86 M(-0.8%)
-$1.78 M(+38.5%)
-$6.86 M(-9.6%)
Jun 2019
-
-$1.28 M(-43.9%)
-$7.59 M(+2.1%)
Mar 2019
-
-$2.29 M(+51.2%)
-$7.44 M(+27.0%)
Dec 2018
-
-$1.51 M(-39.7%)
-$5.86 M(-15.3%)
Sep 2018
-$6.92 M(-7.5%)
-$2.51 M(+122.3%)
-$6.92 M(+30.0%)
Jun 2018
-
-$1.13 M(+59.6%)
-$5.32 M(-12.2%)
Mar 2018
-
-$707.00 K(-72.5%)
-$6.06 M(-24.1%)
Dec 2017
-
-$2.57 M(+181.5%)
-$7.98 M(+6.7%)
Sep 2017
-$7.48 M(-24.4%)
-$913.90 K(-51.0%)
-$7.48 M(-17.0%)
Jun 2017
-
-$1.87 M(-29.0%)
-$9.01 M(-3.8%)
Mar 2017
-
-$2.63 M(+27.1%)
-$9.37 M(+1.4%)
Dec 2016
-
-$2.07 M(-15.4%)
-$9.24 M(-6.6%)
Sep 2016
-$9.90 M(+42.1%)
-$2.45 M(+9.9%)
-$9.90 M(+7.7%)
Jun 2016
-
-$2.23 M(-11.0%)
-$9.19 M(+11.8%)
Mar 2016
-
-$2.50 M(-8.0%)
-$8.22 M(+12.1%)
Dec 2015
-
-$2.72 M(+56.4%)
-$7.33 M(+5.2%)
Sep 2015
-$6.97 M(-18.2%)
-$1.74 M(+38.6%)
-$6.97 M(-6.7%)
Jun 2015
-
-$1.25 M(-22.3%)
-$7.47 M(-9.2%)
Mar 2015
-
-$1.62 M(-31.4%)
-$8.22 M(-6.6%)
Dec 2014
-
-$2.36 M(+5.1%)
-$8.80 M(+3.4%)
Sep 2014
-$8.51 M(+8.2%)
-$2.24 M(+11.6%)
-$8.51 M(+0.8%)
Jun 2014
-
-$2.01 M(-8.5%)
-$8.44 M(+2.4%)
Mar 2014
-
-$2.20 M(+6.3%)
-$8.24 M(+0.6%)
Dec 2013
-
-$2.07 M(-4.9%)
-$8.20 M(+4.1%)
Sep 2013
-$7.87 M(+98.7%)
-$2.17 M(+20.2%)
-$7.87 M(+17.6%)
Jun 2013
-
-$1.81 M(-15.9%)
-$6.69 M(+11.4%)
Mar 2013
-
-$2.15 M(+23.5%)
-$6.01 M(+22.8%)
Dec 2012
-
-$1.74 M(+75.3%)
-$4.89 M(+23.5%)
Sep 2012
-$3.96 M
-$992.70 K(-11.7%)
-$3.96 M(-12.5%)
Jun 2012
-
-$1.12 M(+8.9%)
-$4.53 M(+10.1%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$1.03 M(+27.2%)
-$4.12 M(+0.3%)
Dec 2011
-
-$811.50 K(-48.0%)
-$4.10 M(+9.1%)
Sep 2011
-$3.76 M(+53.2%)
-$1.56 M(+119.8%)
-$3.76 M(+20.3%)
Jun 2011
-
-$710.30 K(-30.4%)
-$3.13 M(+5.9%)
Mar 2011
-
-$1.02 M(+117.2%)
-$2.95 M(+26.2%)
Dec 2010
-
-$469.80 K(-49.3%)
-$2.34 M(-4.8%)
Sep 2010
-$2.46 M(-0.5%)
-$926.40 K(+73.2%)
-$2.46 M(+13.6%)
Jun 2010
-
-$534.90 K(+31.4%)
-$2.16 M(-3.5%)
Mar 2010
-
-$407.10 K(-30.6%)
-$2.24 M(-9.3%)
Dec 2009
-
-$586.80 K(-7.2%)
-$2.47 M(+0.1%)
Sep 2009
-$2.47 M(-15.6%)
-$632.10 K(+2.9%)
-$2.47 M(+2.3%)
Jun 2009
-
-$614.40 K(-3.5%)
-$2.41 M(+11.7%)
Mar 2009
-
-$636.90 K(+8.8%)
-$2.16 M(+3.6%)
Dec 2008
-
-$585.30 K(+1.6%)
-$2.08 M(-28.7%)
Sep 2008
-$2.93 M(+30.0%)
-$576.20 K(+59.3%)
-$2.93 M(-0.6%)
Jun 2008
-
-$361.60 K(-35.6%)
-$2.94 M(-5.5%)
Mar 2008
-
-$561.90 K(-60.6%)
-$3.11 M(-0.1%)
Dec 2007
-
-$1.43 M(+139.9%)
-$3.12 M(+38.4%)
Sep 2007
-$2.25 M(-21.9%)
-$594.60 K(+11.8%)
-$2.25 M(+0.8%)
Jun 2007
-
-$531.90 K(-5.7%)
-$2.23 M(-22.5%)
Mar 2007
-
-$563.90 K(+0.5%)
-$2.88 M(-5.0%)
Dec 2006
-
-$561.20 K(-2.8%)
-$3.03 M(+5.1%)
Sep 2006
-$2.88 M(-68.4%)
-$577.10 K(-51.1%)
-$2.88 M(-16.7%)
Jun 2006
-
-$1.18 M(+65.1%)
-$3.46 M(-30.2%)
Mar 2006
-
-$714.30 K(+72.8%)
-$4.95 M(-37.8%)
Dec 2005
-
-$413.40 K(-64.2%)
-$7.97 M(-12.8%)
Sep 2005
-$9.14 M(+197.8%)
-$1.15 M(-56.9%)
-$9.14 M(+3.7%)
Jun 2005
-
-$2.67 M(-28.2%)
-$8.82 M(+34.1%)
Mar 2005
-
-$3.73 M(+134.8%)
-$6.57 M(+87.5%)
Dec 2004
-
-$1.59 M(+91.0%)
-$3.50 M(+14.2%)
Sep 2004
-$3.07 M(+524.4%)
-$830.70 K(+93.5%)
-$3.07 M(+18.6%)
Jun 2004
-
-$429.40 K(-34.7%)
-$2.59 M(+15.2%)
Mar 2004
-
-$657.90 K(-42.8%)
-$2.25 M(+37.4%)
Dec 2003
-
-$1.15 M(+228.6%)
-$1.64 M(+232.7%)
Sep 2003
-$491.50 K(+4864.6%)
-$350.20 K(+299.3%)
-$491.50 K(+247.8%)
Jun 2003
-
-$87.70 K(+87.8%)
-$141.30 K(+163.6%)
Mar 2003
-
-$46.70 K(+576.8%)
-$53.60 K(+676.8%)
Dec 2002
-
-$6900.00(<-9900.0%)
-$6900.00(-30.3%)
Dec 2001
-$9900.00(+2375.0%)
$0.00(-100.0%)
-$9900.00(-3.9%)
Sep 2001
-
-$9900.00(<-9900.0%)
-$10.30 K(+2475.0%)
Jun 2001
-
$0.00(0.0%)
-$400.00(0.0%)
Mar 2001
-
$0.00(-100.0%)
-$400.00(0.0%)
Dec 2000
-$400.00(-91.3%)
-$400.00(<-9900.0%)
-$400.00(-91.3%)
Sep 2000
-
$0.00(0.0%)
-$4600.00(0.0%)
Jun 2000
-
$0.00(0.0%)
-$4600.00(0.0%)
Mar 2000
-
$0.00(-100.0%)
-$4600.00(0.0%)
Dec 1999
-$4600.00(+53.3%)
-$4600.00(<-9900.0%)
-$4600.00(<-9900.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00
$0.00
Dec 1998
-$3000.00(<-9900.0%)
-
-
Dec 1997
$0.00
-
-

FAQ

  • What is Applied DNA Sciences annual cash flow from operations?
  • What is the all time high annual CFO for Applied DNA Sciences?
  • What is Applied DNA Sciences annual CFO year-on-year change?
  • What is Applied DNA Sciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Applied DNA Sciences?
  • What is Applied DNA Sciences quarterly CFO year-on-year change?
  • What is Applied DNA Sciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Applied DNA Sciences?
  • What is Applied DNA Sciences TTM CFO year-on-year change?

What is Applied DNA Sciences annual cash flow from operations?

The current annual CFO of APDN is -$13.71 M

What is the all time high annual CFO for Applied DNA Sciences?

Applied DNA Sciences all-time high annual cash flow from operations is $0.00

What is Applied DNA Sciences annual CFO year-on-year change?

Over the past year, APDN annual cash flow from operations has changed by -$7.49 M (-120.52%)

What is Applied DNA Sciences quarterly cash flow from operations?

The current quarterly CFO of APDN is -$3.25 M

What is the all time high quarterly CFO for Applied DNA Sciences?

Applied DNA Sciences all-time high quarterly cash flow from operations is $214.40 K

What is Applied DNA Sciences quarterly CFO year-on-year change?

Over the past year, APDN quarterly cash flow from operations has changed by -$39.10 K (-1.22%)

What is Applied DNA Sciences TTM cash flow from operations?

The current TTM CFO of APDN is -$13.71 M

What is the all time high TTM CFO for Applied DNA Sciences?

Applied DNA Sciences all-time high TTM cash flow from operations is $0.00

What is Applied DNA Sciences TTM CFO year-on-year change?

Over the past year, APDN TTM cash flow from operations has changed by -$2.69 M (-24.46%)